ID   B16 melanoma 4A5
AC   CVCL_4612
SY   B164A5; B16-4A5
DR   CLO; CLO_0001790
DR   CLO; CLO_0050758
DR   CLDB; cl335
DR   ChEMBL-Cells; CHEMBL4651378
DR   ECACC; 94042254
DR   IZSLER; BS TCL 184
DR   PubChem_Cell_line; CVCL_4612
DR   RCB; RCB0557
DR   Wikidata; Q54752401
RX   PubMed=23890195;
RX   PubMed=33596583;
CC   Doubling time: 24 hours (PubMed=23890195).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=33596583).
CC   Omics: Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=23890195; DOI=10.1186/1475-2867-13-75;
RA   Danciu C., Falamas A., Dehelean C., Soica C., Radeke H.,
RA   Barbu-Tudoran L., Bojin F., Cinta Pinzaru S., Munteanu M.F.;
RT   "A characterization of four B16 murine melanoma cell sublines
RT   molecular fingerprint and proliferation behavior.";
RL   Cancer Cell Int. 13:75.1-75.12(2013).
//
RX   PubMed=33596583; DOI=10.1159/000513174;
RA   Piaszinski K., Rincic M., Liehr T., Azawi S.;
RT   "Molecular cytogenetic characterization of the murine melanoma cell
RT   lines S91 clone M3 and B16-F1 with variant B16-4A5.";
RL   Cytogenet. Genome Res. 161:82-92(2021).
//